Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Featured News     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Featured News Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

Chinese Pharma Growth Almost Flat in Q2 as Government Heightens Cost Containment Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on interpreting recent pharmaceutical industry and market pe... (11/1/2018) Production of Trustworthy Real World Data and Evidence in China (11/7/2018) Issues in Chinese Foreign Direct Investment in U.S. Early Stage Biotechnology Companies (11/2/2018) Chinese Pharma Growth Almost Flat in Q2 as Government Heightens Cost Containment (11/1/2018) Innovent Biologics Believes It Can Help Usher in A 'Game Changer' for Drug Prices in China (11/1/2018) Bispecific Antibodies in China (10/26/2018) Alibaba and JD.com Operate in Grey Area with Online Drug Sales (10/25/2018) Three Big Pharma Stocks Racing Along the Road to China (10/25/2018) China Is Funding the Future of American Biotech (10/23/2018) China's Pharmaceutical Firms Feel First Impact From Trump's Trade War (10/17/2018) Targeting the Affluent: Differential Access to Targeted Therapies in China (10/16/2018) How to Fulfil Chin'’s Potential for Carrying Out Clinical Trials (10/15/2018) Exploring Ways to Establish Presence in China as Part of APAC Region Push: Lupin Pharma (10/15/2018) China: AstraZeneca’s New Engine for Growth and Innovation (10/9/2018) Biosimilars and Healthcare Policy: What China Can Learn from the EU and US (10/8/2018) Why China Is Going All Out to Invent New, Stronger, Cheaper Drugs (10/8/2018) SAMR Solicits Comments on Vaccine Admini...  (11/12/2018) SAMR Solicits Comments on Production Lic...  (11/12/2018) Guangdong Introduces Implementation Plan...  (11/12/2018) China Step Up Crackdown on Medical Fraud...  (11/11/2018) China Step Up Crackdown on Medical Fraud...  (11/11/2018) Merck KGaA Paves the Way for its Innovat...  (11/11/2018) Performance of Chinese Pharmaceutical In...  (11/9/2018) Recent Executive Moves  (11/9/2018) Amyris Further Expands Relationship with...  (11/8/2018) (free) Ascendis Forms Chinese JV for Endocrinol...  (11/8/2018) NMPA Issues Guidelines for Clinical Tria...  (11/8/2018) NMPA Issues New Announcement (2018#86) f...  (11/8/2018) Leading Chinese Pharma Companies by R&am...  (11/8/2018) Shanghai Promotes Biopharma Innovation w...  (11/7/2018) GE to Produce Single-Use Consumables in ...  (11/7/2018) (free) Top 25 Global Pharmaceutical Companies by Market Cap 201... CANbridge Receives IND Approval to Commence CAN008 Phase... Global Contract Pharmaceutical Manufacturing Market to R... White House Task Force Echoes Pharma Proposals Pharma Industry Reputation Rebounds Somewhat in 2016 Faster Aging of Population Boosts China's Human Vaccine Industr... DB6: Chinese OTC Market Up 6.6% in MAT Q2/2018 IQVIA: Chinese Retail Pharmacy Market Surged 3.9% in MAT Q2/201... IQVIA: Chinese Hospital Drug Market Up 2.8% in MAT Q2/2018 Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Mar... SAMR Solicits Comments on Production Licensing Regulation fo... Merck KGaA Paves the Way for its Innovation Hub in Southern ... Performance of Chinese Pharmaceutical Industry on Steady Gro... Amyris Further Expands Relationship with Yifan Pharma Ascendis Forms Chinese JV for Endocrinology Rare Disease The... NMPA Issues Guidelines for Clinical Trials of Mental and... NMPA Issues New Announcement (2018#86) for Clinical Data... Shanghai Promotes Biopharma Innovation with New Measures... CDE Issues Notice Over Change of Priority Review Publica... NMPA Releases List of Reference Formulations for Generic... SAMR Solicits Comments on Vaccine Administration Law Chinese Lawyer Sues Yunnan Baiyao over False Advertising Genentech Accuses Former Employees of Stealing Drug Secrets ... Changchun Changsheng Biotech Fined CNY 9.1B in Vaccine Scand... New U.S. Rules on Foreign Investment to Curb Chinese Goldrus... Huahai Pharma Faces Lawsuits on Cancer-Causing Valsartan... Zheijiang Huahai Placed under Increased Supervision EU, U.S. and Canada Investigating Second Impurity in Hua... EU Regulators Issue Notice on a Chinese Anticancer API A... USFDA Recalls Thyroid Drugs Containing Chinese API over ... BeiGene Announces Acceptance of Its NDA in China and Top... Green Vally Reports Positive Results in Phase 3 China Tr... CStone Receives USFDA IND Approval for PD-1 mAb CS1003 Reistone Biopharma to Initiate Its Ulcerative Colitis Ph... Chi-Med Starts Phase I Study of HMPL-523 for Leukemia In... Guangdong Introduces Implementation Plan for Generic Dru... China Step Up Crackdown on Medical Frauds by Charities China Step Up Crackdown on Medical Frauds by harities fa... China Aims to Train 500,000 Additional GPs by 2030 NHC Releases 2018 Edition of National Essential Drug Lis... Recent Executive Moves Recent Executive Moves SMIA Announces 17 Departmental Level Senior Official Appoi... Recent Executive Moves Top Chinese Pharma Tycoons Advance on Forbes China Rich Li... China to Launch New Tech Bourse in Shanghai Upcoming Event: 2nd International Conference on Vaccines... Upcoming Event: 31st Annual Cardiologists Conference Upcoming Event: Phar-East 2019 Upcoming Event: Health Insurance Innovation Congress Asi... Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...   WiCON and PharmaGuys Launch Ph...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Its...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links